Novel Fat Depot–Specific Mechanisms Underlie Resistance to Visceral Obesity and Inflammation in 11β-Hydroxysteroid Dehydrogenase Type 1–Deficient Mice
Open Access
- 22 March 2011
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 60 (4) , 1158-1167
Abstract
OBJECTIVE The study objective was to determine the key early mechanisms underlying the beneficial redistribution, function, and inflammatory profile of adipose tissue in 11β-hydroxysteroid dehydrogenase type 1 knockout (11β-HSD1−/−) mice fed a high-fat (HF) diet. RESEARCH DESIGN AND METHODS By focusing on the earliest divergence in visceral adiposity, subcutaneous and visceral fat depots from 11β-HSD1−/− and C57Bl/6J control mice fed an HF diet for 4 weeks were used for comparative microarray analysis of gene expression, and differences were validated with real-time PCR. Key changes in metabolic signaling pathways were confirmed using Western blotting/immunoprecipitation, and fat cell size was compared with the respective chow-fed control groups. Altered adipose inflammatory cell content and function after 4 weeks (early) and 18 weeks (chronic) of HF feeding was investigated using fluorescence (and magnetic)-activated cell sorting analysis, immunohistochemistry, and in situ hybridization. RESULTS In subcutaneous fat, HF-fed 11β-HSD1−/− mice showed evidence of enhanced insulin and β-adrenergic signaling associated with accretion of smaller metabolically active adipocytes. In contrast, reduced 11β-HSD1−/− visceral fat accumulation was characterized by maintained AMP kinase activation, not insulin sensitization, and higher adipocyte interleukin-6 release. Intracellular glucocorticoid deficiency was unexpectedly associated with suppressed inflammatory signaling and lower adipocyte monocyte chemoattractant protein-1 secretion with strikingly reduced cytotoxic T-cell and macrophage infiltration, predominantly in visceral fat. CONCLUSIONS Our data define for the first time the novel and distinct depot-specific mechanisms driving healthier fat patterning and function as a result of reduced intra-adipose glucocorticoid levels.Keywords
This publication has 57 references indexed in Scilit:
- Hypothalamic‐Pituitary‐Adrenal Axis Abnormalities in Response to Deletion of 11β‐HSD1 is Strain‐DependentJournal of Neuroendocrinology, 2009
- Reduced phosphorylation of AS160 contributes to glucocorticoid-mediated inhibition of glucose uptake in human and murine adipocytesMolecular and Cellular Endocrinology, 2009
- Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytesAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Cortisol Release From Adipose Tissue by 11β-Hydroxysteroid Dehydrogenase Type 1 in HumansDiabetes, 2009
- Role of Body Fat Distribution and the Metabolic Complications of ObesityThe Journal of Clinical Endocrinology & Metabolism, 2008
- Mechanisms of macrophage activation in obesity-induced insulin resistanceNature Clinical Practice Endocrinology & Metabolism, 2008
- Inflammation and metabolic disordersNature, 2006
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesityJournal of Clinical Investigation, 2006
- Metabolic and cellular plasticity in white adipose tissue I: effects of β3-adrenergic receptor activationAmerican Journal of Physiology-Endocrinology and Metabolism, 2005